Innoviva (INVA) Liabilities and Shareholders Equity (2010 - 2026)

Innoviva (INVA) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $1.8 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 46.41% year-over-year to $1.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.2 billion (up 24.39% YoY) and the FY2025 annual result came in at $1.6 billion, up 25.68% from the prior year.
• Liabilities and Shareholders Equity climbed to $1.8 billion in Q1 2026, from $1.6 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.8 billion in Q1 2026 to a low of $1.1 billion in Q1 2022.
• A 5-year average of $1.3 billion and a median of $1.2 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 49.65% — and 2023, when it declined 10.51%.
• Tracing INVA's Liabilities and Shareholders Equity over 5 years: stood at $1.2 billion in 2022, then increased by 0.98% to $1.2 billion in 2023, then increased by 4.63% to $1.3 billion in 2024, then climbed by 25.68% to $1.6 billion in 2025, then rose by 12.32% to $1.8 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $1.8 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.